Kim Kamdar
InvestorManaging Partner at Medical Excellence Capital · Partner at Domain Associates
San Diego, California, United States
About
Kim Kamdar, a former Novartis research director and repeat founding CEO (Truvian Sciences, Seraphina Therapeutics), quietly co-founds companies, moves to Chair, and advances global health via Adjuvant Capital.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Experience
- Medical Excellence Capital, LLCManaging Partnercurrent2021 — presentSan Diego, California, United States
- Domain AssociatesPartnercurrent2005 — present
Deals · 2
Evofem BiosciencesBoard seat
via Domain Associates · filed May 2020 · $25M raise
Tragara PharmaceuticalsBoard seat
via Domain Associates · filed Jul 2015 · $1.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Eric Heil
Managing Partner at Medical Excellence Capital
Gregg Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
John Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital
Network2
Investors connected to Kim in public investor directories — a warm-intro map.